Reagents for SARS-CoV-2/COVID-19 Research

Validated Recombinant Proteins for ACE2 & COVID-19 Research

Product NamePIDSourcePurityApplication/Activity
ACE2 (human) (rec.)AG-40B-0192HEK293 cells?95% (SDS-PAGE)Soluble human ACE2 competitively inhibits SARS-CoV-2 infection.
ACE2 (human):Fc (human) (rec.)CHI-B232006HEK293 cells?90% (SDS-PAGE)Soluble human ACE2 competitively inhibits SARS-CoV-2 infection.
ACE2 (mouse) (rec.)AG-40B-0193HEK293 cells?95% (SDS-PAGE)Soluble mouse ACE2 negative control.
SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His)CHI-B232004HEK 293 cells?90% (SDS-PAGE)Soluble Protein S (RBD) competitively inhibits SARS-CoV-2 infection. For drug and antibody screening applications and immunization.
SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) CHI-B232003HEK 293 cells?95% (SDS-PAGE)Soluble Protein S (RBD) competitively inhibits SARS-CoV-2 infection. For drug and antibody screening applications and immunization.
SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.)AG-40B-0194HEK 293 cells?95% (SDS-PAGE)Soluble Protein S (RBD) competitively inhibits SARS-CoV-2 infection. For drug and antibody screening applications and immunization.
SARS-CoV-2 Nucleocapsid Protein (rec.) (His)CHI-B233501E. coli?95% (SDS-PAGE)For drug screening applications.
PLpro (SARS Coronavirus) (rec.) (His)SBB-DE0024E. coli?95% (SDS-PAGE)Involved in the processing of the viral polyprotein.
ISG15 (human) (rec.) (Rhodamine 110)SBB-PS0002E. coli?97% (LCMS)PLPro substrate. Inhibits viral budding and acts as IFN?-inducing cytokine.
Reagents for SARS-CoV-2/COVID-19 Research